Global Erectile Dysfunction Market 2016-2020

Publisher Name :
Date: 28-Sep-2016
No. of pages: 70
Inquire Before Buying

About Erectile Dysfunction

The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The condition can be treated with a broad range of drugs and implants available in the market.

This analyst forecast the global erectile dysfunction treatment market to witness a slow grow in market size of USD 4.08 billion during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the global erectile dysfunction treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of different types of penile implants, ED creams, and drugs, including branded and generic drugs.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

The report, Global Erectile Dysfunction Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Bayer

Boston Scientific

Coloplast

Eli Lilly

Pfizer

Other prominent vendors

Apricus Biosciences

Cristalia Produtos Quimicos Farmaceuticos

Dong-A Socio

Endo Pharmaceuticals

Futura Medical

Meda Pharmaceuticals

Promedon

SK Chemical

Teva Pharmaceuticals

Vivus

Zephyr Surgical Implants (ZSI)

Market driver

Demand from older adult male population

For a full, detailed list, view our report

Market challenge

Threat of counterfeit products

For a full, detailed list, view our report

Market trend

Migration of manufacturing and sales facilities to APAC

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Global Erectile Dysfunction Market 2016-2020

Table of Contents

PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Definition
Vendor segmentation
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by product
Global ED treatment market by product
Global ED drugs market
Global ED devices market
PART 07: Market segmentation by type of ED drugs
Global ED treatment market by type of ED drugs
PART 08: Market segmentation by type of ED device
Global ED treatment market by type of ED device
PART 09: Geographical segmentation
Global ED treatment market by geography
ED treatment market in Americas
ED treatment market in EMEA
ED treatment market in APAC
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
Competitive scenario
PART 16: Key vendor analysis
Bayer
Boston Scientific
Coloplast
Eli Lilly
Pfizer
Other prominent vendors
PART 17: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Global erectile dysfunction treatment market by product
Exhibit 02: Key countries
Exhibit 03: Product offerings
Exhibit 04: Major causes of ED
Exhibit 05: Global ED treatment market 2015-2020 ($ billions)
Exhibit 06: Key drug patent expirations in major countries
Exhibit 07: Five forces analysis
Exhibit 08: Global ED treatment market by product 2015 and 2020
Exhibit 09: Global ED treatment market by product 2015-2020
Exhibit 10: Global ED drugs market 2015-2020 ($ billions)
Exhibit 11: Global ED devices market 2015-2020 ($ millions)
Exhibit 12: ED device market by geography 2015 and 2020
Exhibit 13: Global ED treatment market by type of ED drugs 2015
Exhibit 14: Global ED treatment market by type of ED device 2015 and 2020
Exhibit 15: Global ED treatment market by geography 2015 and 2020
Exhibit 16: Global ED treatment market by geography 2015-2020 ($ millions)
Exhibit 17: ED treatment market in Americas 2015-2020 ($ billions)
Exhibit 18: ED treatment market in Americas by drugs and devices
Exhibit 19: ED treatment market in EMEA 2015-2020 ($ billions)
Exhibit 20: Occurrence of ED by age 2015
Exhibit 21: ED treatment market in EMEA by drugs and devices 2015 and 2020
Exhibit 22: ED treatment market in APAC 2015-2020 ($ millions)
Exhibit 23: ED treatment market in APAC by drugs and devices 2015 and 2020
Exhibit 24: ED treatment Market by product across regions 2015 and 2020 ($ million)
Exhibit 25: Estimated cancer cases and deaths in US 2016 (thousands)
Exhibit 26: Chances of men developing ED by age in the US
Exhibit 27: Number of individuals with diabetes around the world 2015 and 2040 (millions)
Exhibit 28: Impact of drivers
Exhibit 29: Impact of drivers and challenges
Exhibit 30: Bayer: Key takeaways
Exhibit 31: Boston Scientific: Key takeaways
Exhibit 32: Coloplast: Key takeaways
Exhibit 33: Eli Lilly: Key takeaways
Exhibit 34: Pfizer: Key takeaways
  • Global Premature Ejaculation Treatment Market 2017-2021
    Published: 15-Nov-2017        Price: US 3500 Onwards        Pages: 84
    Premature ejaculation is one of the most common sexual dysfunctions occurring in men. Ejaculation happens sooner than desired, either shortly or before penetration, resulting in distress to either one or both partners involved in sexual intercourse. There is no exact cause that can be associated with the condition though mostly, premature ejaculation can be attributed to personal distress and anxiety. It can affect an individual's relationship with his partner. Premature ejaculation is the mo......
  • Benign Prostatic Hyperplasia - Pipeline Review, H2 2017
    Published: 14-Nov-2017        Price: US 2000 Onwards        Pages: 113
    Benign Prostatic Hyperplasia - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Benign Prostatic Hyperplasia - Pipeline Review, H2 2017, provides an overview of the Benign Prostatic Hyperplasia (Male Health) pipeline landscape. Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate, a small gland that encircles the urethra in males and produces a fluid that ma......
  • Secondary (Hypogonadotropic) Hypogonadism - Pipeline Review, H2 2017
    Published: 14-Nov-2017        Price: US 2000 Onwards        Pages: 58
    Secondary (Hypogonadotropic) Hypogonadism - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary (Hypogonadotropic) Hypogonadism - Pipeline Review, H2 2017, provides an overview of the Secondary (Hypogonadotropic) Hypogonadism (Male Health) pipeline landscape. Hypogonadotropic hypogonadism (HH) is a form of hypogonadism that is due to a problem with the pituitary gland or hypothal......
  • Global and Regional Testosterone Replacement Therapy Market Research Report 2017
    Published: 10-Nov-2017        Price: US 3500 Onwards        Pages: 126
    Summary Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type......
  • Erectile Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Erectile Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Erectile Dysfunction. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Erectile Dysfunction wh......
  • Male Hypogonadism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2250 Onwards        Pages: 120
    DelveInsight's, Male Hypogonadism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Male Hypogonadism. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Male Hypogonadism which can t......
  • Global Testosterone Replacement Therapy Market Professional Survey Report 2017
    Published: 01-Nov-2017        Price: US 3500 Onwards        Pages: 117
    This report studies Testosterone Replacement Therapy in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - AbbVie - Endo International - Eli lilly - Pfizer......
  • Erectile Dysfunction - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1500 Onwards        Pages: 70
    DelveInsight's, " Erectile Dysfunction -Pipeline Insights, 2017", report provides comprehensive insights about pipeline drugs across this Erectile Dysfunction. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Erectile Dysfunction. This report provides information on the therapeutic development for Erectile Dysfunction, dealing with all the pipeline drugs and comparative analysis at various stages covering all clinica......
  • Male Hypogonadism - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Male Hypogonadism-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Male Hypogonadism. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Male Hypogonadism by development stage, therapy type, route of administration and molecule type is also covered in the report. It also......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs